Una HbA1c aprox <5.2% antes de las 20 sem de 🤰 descartarían el desarrollo de #diabetes gestacional y por tanto la necesidad de realizar una SOG . SED Diabetes Área Diabetes SEEN

Phase 2a trial for triple hormone receptor agonist #retatrutide for #MASLD. nature.com/articles/s4159…

#PKUDay #DíaMundialDeLaFenilcetonuria Desde Unidad de Metabolopatías de adultos HospitalUVRocio recordamos la importancia de la dieta y suplementación como base del tratamiento. Y la importancia de trabajo en equipo para mejorar la atención, formación e investigación  #CSUR

elespanol.com/ciencia/salud/… Más allá del IMC para diagnosticar la obesidad: "No podemos seguir igual que hace 200 años" nature.com/articles/s4159… “A new framework for the diagnosis, staging and management of obesity in adults” EASO Seedo Vithas Hospitales EL ESPAÑOL

👁‍🗨 Actualización #ManualSEEN 👉 “#Obesidad: enfoque diagnóstico y planteamiento terapéutico integral“ Por los Dres. Natalia Ferre y Miguel Ángel Rubio Herrera, de ObesitySEEN Más info 🖇 swki.me/igBesFBO

When Real Madrid footballer, Nacho Fernandez, was diagnosed with #Type1Diabetes at 12 years old, he was told his footballing days were over 💙⚽ This Sunday, Nacho is playing for Spain in the #EURO2024 final! #T1D doesn’t stop you from following your dreams! #GBDoc

El beneficio del control glucémico inicial dura, y dura, y dura (UKPDS a 24 años) - Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91) - The Lancet thelancet.com/journals/lance…

In the FLOW trial, researchers assessed whether the glucagon-like peptide 1 receptor agonist semaglutide was effective in preventing progression of kidney disease in patients with type 2 diabetes and chronic kidney disease. Full trial results: nej.md/44U3slP

Oral insulin may delay progression to stage 3 type 1 diabetes among individuals who carry HLA DR4-DQ8 and/or have elevated IA-2A levels. Future trials studying oral insulin should characterize HLA endotypes. ADA Professional Publications Read Here➡️ diabetesjournals.org/care/lookup/do…

As GLP-1 science expands beyond glucose control #T2D and #weightloss new indications are being explored in the clinic, highlighting potential roles for GLP-1 in neuroprotection, substance use disorders, metabolic liver disease and more Science Magazine science.org/doi/10.1126/sc…

The August 2024 issue of Diabetes Care is live at diabetesjournals.org/care/issue/47/8, featuring latest scholarly research on the care of #diabetes. In This Issue: - CGM Profiles in Pregnancies w/ and w/out Gestational Diabetes Mellitus - Lessons from Insulin - And More!

For patients with metabolic dysfunction–associated steatohepatitis and liver fibrosis, survodutide, a dual agonist of the glucagon and GLP-1 receptors, may confer clinical advantages. Research findings are summarized in a new Quick Take video. nej.md/3SmZ2im

A win for Tirzepatide in HFpEF #heartfailure investor.lilly.com/news-releases/…

Nutrient Status and Intakes of Adults with #PKU No diferencia en DHA ni otros micronutrientes, salvo selenio y algunos AA  🔝suplementos específicos para alcanzar requerimientos proteicos  Nutrients MDPI Eva Venegas EndocrinoHUVR Alvaro Hermida AECOM, Asociación Española para estudio de los ECM mdpi.com/2072-6643/16/1…

In 31 hemodialysis patients with #diabetes, although MARD values were higher than traditional optimal analytic performance thresholds, error grids showed nearly all Dexcom G6 CGM values were in clinically acceptable zones Diabetes Care, a research journal of the ADA 🌟 diabetesjournals.org/care/article-a…

In patients with #T2D, slower decline in eGFR was seen with #SGLT2i than with #GLP1RA, supporting SGLT2i as preferred agents for renal protection in #diabetes. Results of a new observational study performed by the Italian Diabetes Society tinyurl.com/mrxs83rd 🔓

Diabetes asociada a enfermedad exocrina del páncreas. Tipo específico de DM, con necesidades terapéuticas propias. Nuevo capítulo Manual SEEN. manual.seen.es/article?id=66c… Sociedad SEEN Área Diabetes SEEN

La noticia tecnológica en #diabetes de las últimas horas es el acuerdo de colaboración entre Dexcom y Novo Nordisk España para compartir los datos de sus dispositivos e integrarlos en varias plataformas. Más info canaldiabetes.com/dexcom-y-novo-…

Read our DIABETES & TECHNOLOGY special issue: inc 9 reviews on diabetes tech use in T1D, T2D, older adults, children, pregnancy, CFRD, CKD, hospital settings & exercise. Also including the views of people living with diabetes and an editorial by Kar & co diabetologia-journal.org/collections/di…

📕Biomarkers to inform the management of polycystic ovary syndrome: A review of systematic reviews ✍️ Se identificaron 22 biomarcadores centrales que evalúan el impacto multisistémico del #SOP e informan su manejo clínico onlinelibrary.wiley.com/doi/full/10.11… GRUPO GIDSEEN